Category: Featured

Integrate DrugPatentWatch Into Your Application or Data Store

Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs and the 1.3 million global patents and applications covering them. DrugPatentWatch was founded in 2002, and has served large and small companies throughout the biopharmaceutical value chain. The platform has also been cited by CNN, NEJM, Nature Journals, and […]


Patenting the Microbiome

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In recognition of World IP Day, I thought it would be nice to share a hopeful update relating to patentability of emerging Microbiome technologies holding great promise for patients […]


New features from DrugPatentWatch – Bulk API sources and clinical trials

After months of development and feedback from customers, DrugPatentWatch is proud to announce the availability of two new datasets: Bulk API Sources and Clinical Trials. The addition of Bulk API sources complements the existing Suppliers / Packagers dataset. While the Suppliers / Packagers provides information where to source on finished products, the Bulk API Sources lists […]


FDA Orange Book Archives

Approved Drug Products With Therapeutic Equivalance Evaluations In addition to its deep database of global drug and patent information, DrugPatentWatch also has archives of the Food and Drug Administration (FDA) Orange Book, or Approved Drug Products With Therapeutic Equivalence Evaluationscatalogs. The Orange Book identifies drug products approved on the basis of safety and effectiveness by […]


Brexit and British Biotech

Brexit and British biotechnology

I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom. I have been measuring global biotechnology for eight years and my objective data-driven metrics provide both a baseline to gauge future directions, and guidance for how to improve the sector’s performance. Eight years ago I […]


FDA Orange Book Archives From 1980 to Present

Download FDA Orange Book Archives in PDF Format

DrugPatentWatch offers PDF copies of the FDA Orange Book dating back to 1980. The Food and Administration (FDA) Orange Book, or Approved Drug Products With Therapeutic Equivalence Evaluations, is an authoritative list of patents covering branded drugs, and of generic equivalents. The Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA […]


Book signing sold out at #BIO2016

My book signing sold out, but do not despair — you can still get a signed copy. Signed copies of Building Biotechnology can be purchased at http://www.BuildingBiotechnology.com , and you can also get regular copies at Amazon. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define […]


Scientific American Worldview Issue 6 at #BIO2014

I continue to measure global biotechnology innovation in the sixth edition of Scientific American Worldview. This special publication is the foundation I use for my talks on global biotechnology (see my recent talk on Building Biotechnology in India). I will be serving on a panel on June 26th at 12:45-1:45 in Room 3, and David Brancaccio, host of […]


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: